Pharmaceutical packaging materials serve as the first line of defense to ensure drug quality; however, the use of the material itself potentially possesses a risk of drug contamination.In recent years, increased concern surrounding extractables and leachables (E&L) in pharmaceutical drug products have been raised by the U.S. Food and Drug Administration (FDA) and European Medicines Evaluation Agency (EMEA).The primary concern of E&L evaluation is the public health and safety, as these chemicals could have toxicity, immunogenicity or potentially interactions with the active ingredients in the product.Additionally, these chemicals could lead to drug efficacy loss or a decrease in drug stability during storage [1].Furthermore, the effects of these chemicals on biologics are unknown and unpredictable.The possible effects include biological molecules folding, state changes, aggregation, oxidation, formation of particulate matter etc.